frontline atezolizumab for advanced bladder cancer
Published 7 years ago • 169 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
0:55
dr. siefker-radtke on fda approval of frontline atezolizumab in bladder cancer
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
3:36
frontline immunotherapy in advanced bladder cancer
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
1:20
dr. rosenberg on future use of atezolizumab in bladder cancer
-
1:32
tecentriq (atezolizumab) approved to treat advanced bladder cancer
-
3:00
atezolizumab limits disease progression for metastatic urothelial bladder cancer
-
1:27
fda approval of atezolizumab for nsclc
-
1:34
fda approves frontline nivolumab for advanced melanoma
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
4:55
atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
-
1:09
dr. plimack on frontline pembrolizumab for urothelial carcinoma
-
1:29
dr. daniel petrylak on the imvigor study of atezolizumab in advanced bladder cancer
-
4:14
imbrave150 trial: frontline treatment of advanced hcc
-
6:45
activity of immunotherapy in the frontline setting
-
0:46
dr. sonpavde on the need for phase 3 data with pembrolizumab or atezolizumab in bladder cancer